Imux
1 known investors
Immunic Therapeutics is a late-stage biotechnology company developing orally administered small molecule therapies for neurologic, chronic inflammatory, and autoimmune diseases. Its clinical programs target conditions including multiple sclerosis and celiac disease.
Investors Β· 1
Frequently asked questions
- What does Imux do?
- Immunic Therapeutics is a late-stage biotechnology company developing orally administered small molecule therapies for neurologic, chronic inflammatory, and autoimmune diseases. Its clinical programs target conditions including multiple sclerosis and celiac disease.
- Who are Imux's investors?
- Imux's investors include Fund+.